A detailed history of Capital Fund Management S.A. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Capital Fund Management S.A. holds 171,582 shares of GH stock, worth $5.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
171,582
Previous 178,219 3.72%
Holding current value
$5.38 Million
Previous $5.15 Million 23.55%
% of portfolio
0.01%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$22.3 - $36.29 $148,005 - $240,856
-6,637 Reduced 3.72%
171,582 $3.93 Million
Q2 2024

Aug 13, 2024

SELL
$16.07 - $31.84 $2.15 Million - $4.26 Million
-133,812 Reduced 42.88%
178,219 $5.15 Million
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $1.78 Million - $2.79 Million
103,702 Added 49.78%
312,031 $6.44 Million
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $269,598 - $368,543
-12,493 Reduced 5.66%
208,329 $5.64 Million
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $402,118 - $622,972
-15,586 Reduced 6.59%
220,822 $6.55 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $170,137 - $308,831
8,125 Added 3.56%
236,408 $8.46 Million
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $2.44 Million - $3.6 Million
106,489 Added 87.43%
228,283 $5.35 Million
Q4 2022

Feb 13, 2023

BUY
$25.44 - $59.78 $3.1 Million - $7.28 Million
121,794 New
121,794 $3.31 Million
Q1 2022

May 12, 2022

SELL
$48.25 - $100.49 $767,512 - $1.6 Million
-15,907 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$88.71 - $120.43 $1.41 Million - $1.92 Million
15,907 New
15,907 $1.59 Million
Q2 2020

Aug 13, 2020

SELL
$60.49 - $97.5 $442,302 - $712,920
-7,312 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$59.04 - $88.81 $431,700 - $649,378
7,312 New
7,312 $508,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.21B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.